9%
Sponsors
Seelos Therapeutics Inc., Eagle Pharmaceuticals Inc., ASST Grande Ospedale Metropolitano Niguarda, Universite De Liege, CHU De Liege, Assistance Publique Hopitaux De Paris
Conditions
Acute Myocardial InfarctionAdult Patients kidney transplant recipients who have developed chronic humoral rejectionBurn injuryCOVID-19 and fluDisorder of ConsciousnessMajor Depression DisordersOpioid use disorderRecovery following elective minimally invasive colorectal surgery
Phase 1
Phase 2
A DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED TRIAL TO ASSESS SAFETY AND EFFICACY OF SLS-005 (TREHALOSE INJECTION, 90.5 MG/ML FOR INTRAVENOUS INFUSION) FOR THE TREATMENT OF ADULTS WITH SPINOCEREBELLAR ATAXIA
CompletedCTIS2022-501004-10-00
Start: 2023-01-30End: 2024-02-12Target: 58Updated: 2023-03-10
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CAL02 ADMINISTERED INTRAVENOUSLY IN ADDITION TO STANDARD OF CARE IN SUBJECTS WITH SEVERE COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA (SCABP)
SuspendedCTIS2022-502049-91-00
Start: 2023-09-26Target: 81Updated: 2025-09-24
Treating severe brain-injured patients with apomorphine : a behavioural and neuroimaging study
RecruitingCTIS2023-504631-40-01
Start: 2018-09-05Target: 102Updated: 2025-07-24
CONCOMITANT ADMINISTRATION OF LICENSED VACCINES AGAINST COVID-19 AND FLU WITH OR WITHOUT MF59 ADJUVANT: A MULTI-CENTRE, RANDOMIZED, SINGLE-BLIND CLINICAL TRIAL TO ASSESS IMMUNOGENICITY IN ADULTS AGED 65 AND OVER
CompletedCTIS2024-514798-23-00
Start: 2024-10-02End: 2025-03-04Target: 120Updated: 2024-10-14
SCARR : « Allogenic Umbilical Cord Mesenchymal Stromal Cells for the treatment of chronic renal (cABMR) graft rejection »
Not yet recruitingCTIS2023-506598-36-00
Target: 22Updated: 2025-08-01
A Randomized, Single-Blind, Fixed-Order Crossover Study to Assess the Effects of CSX-1004 Injection on Fentanyl-Induced Respiratory Depression in Healthy Adult Subjects and Subjects with Opioid Use Disorder
Not yet recruitingCTIS2025-524133-33-00
Target: 24Updated: 2026-03-20
Phase 3
Continuous Wound Infiltration versus placebo following elective minimally invasive colorectal surgery; a double-blinded, randomised, placebo-controlled, low-intervention trial (CIMICS trial)
RecruitingCTIS2024-512107-39-00
Start: 2024-10-30Target: 192Updated: 2024-07-11
Single blind randomized controlled trial to assess the safety and efficacy of high dose pulse intravenous corticosteroid therapy to treat patients with complicated/fulminant acute myocarditis
Not yet recruitingCTIS2023-504169-22-02
Target: 120Updated: 2025-05-12
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-center Study to Compare the Anti-Depressive Efficacy and Safety of Samyr® IM versus Placebo IM as an Enhancer Adjunctive to Antidepressant Treatment in Major Depression Disorder Patients Who have not Experienced Sufficient Symptoms Improvement Despite Antidepressant Treatment
RecruitingCTIS2024-513022-29-00
Start: 2019-01-09Target: 468Updated: 2026-01-20
The effect of phoSPHocreatine on mEdical emergency team (met) tREated patients: a randomized clinical trial protocol – SPHERE
Not yet recruitingCTIS2024-518474-14-00
Target: 350Updated: 2025-10-15
MAMI Use of the Methoxyflurane as pain-killer in the prehospital management of Acute Myocardial Infarction
WithdrawnCTIS2023-507296-21-00
Target: 700Updated: 2025-06-13
MAMI Use of the Methoxyflurane as pain-killer in the prehospital management of Acute Myocardial Infarction
Not yet recruitingCTIS2025-523349-86-00
Target: 700Updated: 2026-02-02